Latigo Biotherapeutics Inc

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LTGO and other ETFs, options, and stocks.

About LTGO

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418.

CEO

Nima M. Farzan, MBA

CEONima M. Farzan, MBA

Employees

—

Employees—

Headquarters

Thousand Oak, California

HeadquartersThousand Oak, California

Founded

Employees

—

Employees—

LTGO Key Statistics

Market cap

1.08B

Market cap1.08B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

Stock Snapshot

With a market cap of 1.08B, Latigo Biotherapeutics Inc(LTGO) trades at $18.00.

On 2026-08-07, Latigo Biotherapeutics Inc(LTGO) stock opened at —, reached a high of —, and a low of —.

The Latigo Biotherapeutics Inc(LTGO)'s current trading volume is 0.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.